4.7 Article

Insulin receptor-mediated signaling regulates pluripotency markers and lineage differentiation

Journal

MOLECULAR METABOLISM
Volume 18, Issue -, Pages 153-163

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.molmet.2018.09.003

Keywords

Insulin receptor signaling; Pluripotency; Lineage differentiation; Adipocyte; Beta cells; Neurons; Stem cells; Phosphoproteomics; Reprogramming

Funding

  1. Joslin Diabetes Center iPS Core Facility (DRC) [NIH DK036836]
  2. JDRF advanced postdoctoral fellowship [3-APF-2017-393-A-N]
  3. Portuguese Foundation for Science and Technology - FCT [SFRH/BD/51699/2011]
  4. Albert Ronald Travel Fellowship
  5. HSCI
  6. NIH [R01DK077097, R01DK102898, R01 DK67536, R01 DK103215, UC4 DK104167, DP3 DK110844]
  7. American Diabetes Association Fellowship [1-18-PDF-169]
  8. DOE [DE-AC05-76RL0 1830]
  9. DOE
  10. 2016 FLAD R&D@PhD Internship Grant
  11. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104167, R01DK077097, P30DK036836, R01DK102898, DP3DK110844] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Objectives: Insulin receptor (IR)-mediated signaling is involved in the regulation of pluripotent stem cells; however, its direct effects on regulating the maintenance of pluripotency and lineage development are not fully understood. The main objective of this study is to understand the role of IR signaling in pluripotency and lineage development. Methods: To explore the role of IR signaling, we generated IR knock-out (IRKO) mouse induced pluripotent stem cells (miPSCs) from E14.5 mouse embryonic fibroblasts (MEFs) of global IRKO mice using a cocktail of four reprogramming factors: Oct4, Sox2, Klf4, cMyc. We performed pluripotency characterization and directed the differentiation of control and IRKO iPSCs into neural progenitors (ectoderm), adipocyte progenitors (mesoderm), and pancreatic beta-like cells (endoderm). We mechanistically confirmed these findings via phosphoproteomics analyses of control and IRKO iPSCs. Results: Interestingly, expression of pluripotency markers including Klf4, Lin28a, Tbx3, and cMyc were upregulated, while abundance of Oct4 and Nanog were enhanced by 4-fold and 3-fold, respectively, in IRKO iPSCs. Analyses of signaling pathways demonstrated downregulation of phospho-STAT3, p-mTor and p-Erk and an increase in the total mTor and Erk proteins in IRKO iPSCs in the basal unstimulated state. Stimulation with leukemia inhibitory factor (LIF) showed a w33% decrease of phospho-ERK in IRKO iPSCs. On the contrary, Erk phosphorylation was increased during in vitro spontaneous differentiation of iPSCs lacking IRs. Lineage-specific directed differentiation of the iPSCs revealed that cells lacking IR showed enhanced expression of neuronal lineage markers (Pax6, Tubb3, Ascl1 and Oligo2) while exhibiting a decrease in adipocyte (Fas, Acc, Pparg, Fabp4, C/ebpa, and Fsp27) and pancreatic beta cell markers (Ngn3, Isl1, and Sox9). Further molecular characterization by phosphoproteomics confirmed the novel IR-mediated regulation of the global pluripotency network including several key proteins involved in diverse aspects of growth and embryonic development. Conclusion: We report, for the first time to our knowledge, the phosphoproteome of insulin, IGF1, and LIF stimulation in mouse iPSCs to reveal the importance of insulin receptor signaling for the maintenance of pluripotency and lineage determination. (C) 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available